DOI: 10.1055/s-00000142

Frauenheilkunde up2date

References

Mahadevan U, Vermeire S, Lasch K. et al.
Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease.

Aliment Pharmacol Ther 2017;
45: 941-950

Download Bibliographical Data

Access: